24 May 2013
Keywords: vertex, novartis, amend, collaboration, usa, swiss, drug
Article | 09 February 2004
Vertex of the USA and Swiss drug major Novartis have amended their collaboration directed at targets in the protein kinase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 February 2004
23 May 2013
© 2013 thepharmaletter.com